Cargando…

Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank

Background: Irritable bowel syndrome (IBS) reduces patients’ quality of life and causes great burdens due to its unclear pathogenesis and criteria for diagnosis. This study aimed to explore the differences in prevalence and the influencing factors for IBS and its subtypes. Methods: The UK Biobank su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kexin, Liu, Huan, Liu, Jingjing, Han, Liyuan, Kang, Zheng, Liang, Libo, Jiang, Shengchao, Meng, Nan, Chen, Peiwen, Xu, Qiao, Wu, Qunhong, Hao, Yanhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458926/ https://www.ncbi.nlm.nih.gov/pubmed/36091797 http://dx.doi.org/10.3389/fphar.2022.905564

Ejemplares similares

Global, Regional, and National Estimates of Nutritional Deficiency Burden among Reproductive Women from 2010 to 2019
por: Jiang, Shengchao, et al.
Publicado: (2022)

Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017
por: Liu, Jingjing, et al.
Publicado: (2021)

Evaluating the role of anxiety on the association between irritable bowel syndrome and brain volumes: a mediation analysis in the UK Biobank cohort
por: Meng, Peilin, et al.
Publicado: (2023)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
por: Jun, Hyejin, et al.
Publicado: (2022)

Drug Development for the Irritable Bowel Syndrome: Current Challenges and Future Perspectives
por: De Ponti, Fabrizio
Publicado: (2013)

Novel insights which may translate into treatments for irritable bowel syndrome
por: Izzo, Angelo A.
Publicado: (2013)

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan
por: Lai, Yu-Tung, et al.
Publicado: (2021)

Evolving Patterns of Nutritional Deficiencies Burden in Low- and Middle-Income Countries: Findings from the 2019 Global Burden of Disease Study
por: Liu, Jingjing, et al.
Publicado: (2022)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Li, Bing, et al.
Publicado: (2020)

Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis
por: Tian, Siyu, et al.
Publicado: (2023)

Minimizing the Risk of Catastrophic Health Expenditure in China: A Multi-Dimensional Analysis of Vulnerable Groups
por: Wang, Jiahui, et al.
Publicado: (2021)

Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle
por: Lu, Yulin, et al.
Publicado: (2021)

Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats
por: Chen, Hui-Yu, et al.
Publicado: (2022)

Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization
por: Bao, Wenzhao, et al.
Publicado: (2022)

Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis
por: Wu, Peng-Ning, et al.
Publicado: (2022)

Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis
por: Xiao, Jin, et al.
Publicado: (2023)

Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis
por: Qin, Di, et al.
Publicado: (2022)

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
por: Xie, Chao-Rong, et al.
Publicado: (2022)

Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome
por: Ling, Xiwen, et al.
Publicado: (2022)

Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan
por: Gu, Ye, et al.
Publicado: (2023)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome
por: Su, Qi, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Evaluation of Psychological Aspects Among Subtypes of Irritable Bowel Syndrome
por: Farzaneh, Neda, et al.
Publicado: (2012)

trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis
por: Xu, Ying, et al.
Publicado: (2018)

Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo
por: Li, Lei, et al.
Publicado: (2020)

Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats
por: Zhou, Hui-hui, et al.
Publicado: (2021)

Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats
por: Chen, Wanyu, et al.
Publicado: (2022)

Irritable bowel syndrome subtype screening characteristics: constipation subtype patient profiles explored
por: Anastasi, Joyce K., et al.
Publicado: (2012)

Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study
por: Zhang, Xiaoying, et al.
Publicado: (2023)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Chinese Herbal Medicine for Irritable Bowel Syndrome: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
por: Zheng, Hui, et al.
Publicado: (2021)

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021)

Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers
por: Yu, Qihong, et al.
Publicado: (2019)

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome
por: Clarke, Gerard, et al.
Publicado: (2012)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2016)

Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials
por: Liang, Shi-Bing, et al.
Publicado: (2022)

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
por: Jacobs, Jonathan P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_870c8pn16on8plro6j9m7hq2st